Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Software | 15 | 2022 | 4443 | 0.850 |
Why?
|
Computer Graphics | 4 | 2022 | 361 | 0.420 |
Why?
|
Microscopy | 4 | 2022 | 903 | 0.330 |
Why?
|
Systems Biology | 2 | 2019 | 469 | 0.250 |
Why?
|
Data Mining | 2 | 2019 | 537 | 0.230 |
Why?
|
Neoplasms | 5 | 2022 | 21683 | 0.220 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2023 | 2043 | 0.220 |
Why?
|
Computational Biology | 6 | 2021 | 3521 | 0.200 |
Why?
|
Database Management Systems | 3 | 2011 | 270 | 0.170 |
Why?
|
Kidney Tubules, Proximal | 2 | 2019 | 416 | 0.170 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.170 |
Why?
|
Toxicology | 1 | 2019 | 106 | 0.160 |
Why?
|
Cataloging | 1 | 2017 | 8 | 0.160 |
Why?
|
Melanoma | 3 | 2023 | 5510 | 0.150 |
Why?
|
Ecosystem | 1 | 2021 | 474 | 0.150 |
Why?
|
Programming Languages | 3 | 2013 | 133 | 0.150 |
Why?
|
MAP Kinase Signaling System | 2 | 2023 | 1526 | 0.150 |
Why?
|
Heme Oxygenase-1 | 2 | 2019 | 381 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 8949 | 0.140 |
Why?
|
Kidney Diseases | 2 | 2019 | 2149 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.130 |
Why?
|
Toxicity Tests | 1 | 2015 | 121 | 0.130 |
Why?
|
Models, Biological | 4 | 2013 | 9583 | 0.120 |
Why?
|
Data Collection | 1 | 2022 | 3341 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1990 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.090 |
Why?
|
Natural Language Processing | 1 | 2017 | 1041 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10943 | 0.090 |
Why?
|
Fuzzy Logic | 1 | 2009 | 56 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2183 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2023 | 16689 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 648 | 0.080 |
Why?
|
Phosphotransferases | 1 | 2009 | 308 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
Models, Genetic | 1 | 2017 | 3494 | 0.070 |
Why?
|
Cell Death | 1 | 2013 | 1706 | 0.070 |
Why?
|
Internet | 5 | 2021 | 3064 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1676 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 708 | 0.070 |
Why?
|
Databases, Protein | 1 | 2008 | 383 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8428 | 0.070 |
Why?
|
Glioblastoma | 1 | 2020 | 3481 | 0.060 |
Why?
|
Receptor, Insulin | 1 | 2009 | 846 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 625 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2013 | 2309 | 0.060 |
Why?
|
Signal Transduction | 4 | 2020 | 23403 | 0.060 |
Why?
|
Gene Library | 2 | 2017 | 1074 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2017 | 780 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1375 | 0.050 |
Why?
|
Computer Simulation | 5 | 2017 | 6196 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9438 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 5172 | 0.050 |
Why?
|
Databases, Factual | 3 | 2019 | 7729 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
Humans | 20 | 2023 | 744343 | 0.040 |
Why?
|
User-Computer Interface | 3 | 2014 | 1431 | 0.040 |
Why?
|
Genes, Essential | 1 | 2021 | 183 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3586 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8863 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2019 | 299 | 0.040 |
Why?
|
Enzymes | 1 | 2020 | 266 | 0.040 |
Why?
|
Tissue Fixation | 1 | 2019 | 241 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3505 | 0.040 |
Why?
|
Computers | 1 | 2021 | 612 | 0.040 |
Why?
|
Formaldehyde | 1 | 2019 | 353 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5686 | 0.040 |
Why?
|
Cell Shape | 1 | 2019 | 375 | 0.040 |
Why?
|
Information Storage and Retrieval | 2 | 2017 | 824 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1799 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3507 | 0.040 |
Why?
|
Animals | 4 | 2022 | 168757 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2009 | 2541 | 0.040 |
Why?
|
Kinetics | 2 | 2014 | 6473 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13102 | 0.030 |
Why?
|
ras Proteins | 1 | 2020 | 1060 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.030 |
Why?
|
Cell Line | 3 | 2017 | 15997 | 0.030 |
Why?
|
National Health Programs | 1 | 2017 | 445 | 0.030 |
Why?
|
Proteins | 2 | 2020 | 6103 | 0.030 |
Why?
|
Research Design | 1 | 2008 | 5987 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19229 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.020 |
Why?
|
Calibration | 1 | 2013 | 816 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1692 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2019 | 2969 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20822 | 0.020 |
Why?
|
Interleukins | 1 | 2014 | 791 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1839 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12072 | 0.020 |
Why?
|
Language | 1 | 2017 | 1471 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 720 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1938 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 871 | 0.020 |
Why?
|
Peptides | 1 | 2020 | 4409 | 0.020 |
Why?
|
Chemistry | 1 | 2007 | 352 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2432 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1254 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2007 | 518 | 0.020 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13695 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2948 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2715 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3282 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3798 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2015 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1434 | 0.020 |
Why?
|
Antibodies | 1 | 2014 | 2460 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1356 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 13881 | 0.020 |
Why?
|
Biological Assay | 1 | 2007 | 652 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2014 | 2416 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81183 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Drug Discovery | 1 | 2010 | 1058 | 0.010 |
Why?
|
Genome | 1 | 2010 | 1808 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2889 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2013 | 3589 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
Mitochondria | 1 | 2013 | 3520 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 1071 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4838 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9727 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
Female | 3 | 2014 | 380194 | 0.010 |
Why?
|
Male | 1 | 2014 | 350118 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_